Is Atrial Fibrillation a Risk Factor for Hearing Loss
dc.authorid | 0000-0001-8145-9574 | |
dc.authorscopusid | 6701320818 | |
dc.authorscopusid | 58429627600 | |
dc.authorwosid | Karahan, Zulkuf/Jvm-8829-2024 | |
dc.contributor.author | Karahan, M. Z. | |
dc.contributor.author | Karahan, Mehmet Zülkif | |
dc.contributor.author | Can, S. | |
dc.contributor.other | Department of Internal Medical Sciences / Dahili Tıp Bilimleri Bölümü | |
dc.date.accessioned | 2023-12-12T16:35:19Z | |
dc.date.available | 2023-12-12T16:35:19Z | |
dc.date.issued | 2023 | |
dc.department | Artuklu University | en_US |
dc.department-temp | [Karahan, M. Z.] Mardin Artuklu Univ, Fac Med, Dept Cardiol, Mardin, Turkiye; [Can, S.] Dicle Univ, Fac Med, Otorhinolaryngol & Head & Neck Surg Clin, Diyarbakir, Turkiye | en_US |
dc.description.abstract | OBJECTIVE: In the present study, we sought to evaluate the results of hearing loss in AF patients. PATIENTS AND METHODS: This study involved 50 patients with AF, as determined by means of electrocardiogram, and 50 patients without AF. The pure-tone audiometry (PTA) threshold values were measured at low, medium and high frequencies for both ears. The signal-to-noise ratio (SNR) DPOAEs and TEOAEs were also analyzed for both ears separately. RESULTS: Both the airway and bone conduction PTA thresholds at 3, 4 and 6 kHz (kilohertz) were significantly lower in the AF group than in the control group (p<0.05). The AF patients exhibited worse hearing and worse TEO-AE results at 1, 2, 3 and 4 kHz. In fact, the TEO-AE amplitudes of the AF group were significantly lower in both the right and left ears at 2, 3 and 4 kHz when compared with the control group (p<0.05). Moreover, the DPOAE amplitudes in the AF group were statistically significantly lower at 3.4 kHz in both ears when compared with the control group (p<0.05). CONCLUSIONS: In light of these findings, we believe that AF is a risk factor for hearing. | en_US |
dc.description.woscitationindex | Science Citation Index Expanded | |
dc.identifier.doi | 10.26355/eurrev_202306_32632 | |
dc.identifier.endpage | 5158 | en_US |
dc.identifier.issn | 1128-3602 | |
dc.identifier.issue | 11 | en_US |
dc.identifier.pmid | 37318489 | |
dc.identifier.scopus | 2-s2.0-85163904210 | |
dc.identifier.scopusquality | Q2 | |
dc.identifier.startpage | 5153 | en_US |
dc.identifier.uri | https://doi.org/10.26355/eurrev_202306_32632 | |
dc.identifier.volume | 27 | en_US |
dc.identifier.wos | WOS:001020918300005 | |
dc.identifier.wosquality | Q2 | |
dc.language.iso | en | en_US |
dc.publisher | verduci Publisher | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.scopus.citedbyCount | 0 | |
dc.subject | Atrial Fibrillation | en_US |
dc.subject | Hearing Loss | en_US |
dc.subject | Cochlea | en_US |
dc.subject | Cardiac Output | en_US |
dc.title | Is Atrial Fibrillation a Risk Factor for Hearing Loss | en_US |
dc.type | Article | en_US |
dc.wos.citedbyCount | 0 | |
dspace.entity.type | Publication | |
relation.isAuthorOfPublication | 1cf334d3-4ee1-4f6d-8af1-cb0cba29287d | |
relation.isAuthorOfPublication.latestForDiscovery | 1cf334d3-4ee1-4f6d-8af1-cb0cba29287d | |
relation.isOrgUnitOfPublication | 8e5859b2-b0cf-4e18-9816-a07bcf1aa7ca | |
relation.isOrgUnitOfPublication.latestForDiscovery | 8e5859b2-b0cf-4e18-9816-a07bcf1aa7ca |